NSEAnalysts/Institutional Investor Meet/Con. Call Updates4 Aug 2026 · 4 Aug 2026, 07:28 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Alembic Pharmaceuticals Limited · APLLTD

✦ AI SummaryResults

Alembic Pharmaceuticals Limited has informed the Exchange about the link of recording of the post-results conference call held on 4th August, 2026. The audio recording is hosted on the company's website at https://alembicpharmaceuticals.com/quarterly-results.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording

Attachments (1)

📄

APLLTD_04082026192747_Intimation_Audio_Recording_Investor_Call_S.pdf

pdf

Download →
View document text
Date: 4th August, 2026 To, To, The Manager, The Manager, Department of Corporate Services, Listing Department, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 533573 NSE Symbol: APLLTD Dear Sir/Madam, Sub: Submission of Audio Recording of Post Results Conference Call held on 4th August, 2026 Ref: Our Intimation dated 27th July, 2026 With reference to the captioned subject, this is to inform the exchanges that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results We request you to kindly take the same on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Manisha Saraf Company Secretary ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123